FOLH1 and posterior cortical atrophy: A total of 40 patients with advanced PCa and positive PSMA uptake were treated in 4 escalating dose cohorts of 4 GBq, 6 GBq, 7.4 GBq or 9.3 GBq 177Lu-PSMA every 8 weeks for 3 cycles [133].